Replies to post #150520 on Rivulet Media Inc (fka RIVU)

[vegasdrummer]

Then what does

Regen BioPharma Inc. announced today that it has received final comments and authorization from the FDA to proceed with its GLP Safety Study in support of the company's HemaXellerate Investigational New Drug application (IND) which is on file with the FDA.